Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: NYSE
DilutionScan read 17 of Annovis Bio, Inc.'s SEC filings and found 7 warrant series, 1 ATM program, 1 equity line, 1 shelf registration and 4 completed offerings on file for ANVS. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Oct 4, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
MREOMereo BioPharma Group plc American Depositary Shares
BMEABiomea Fusion, Inc.
CRBUCaribou Biosciences, Inc.
ATHEAlterity Therapeutics Limited American Depositary Shares
TILInstil Bio, Inc.
CNTBConnect Biopharma Holdings Limited
IMAImageneBio Inc
LONALeonaBio, Inc.
ATNMActinium Pharmaceuticals, Inc.
EXOZeXoZymes, Inc.
SERSerina Therapeutics, Inc.
GANXGain Therapeutics, Inc.
PTHSPelthos Therapeutics Inc.
KLRSKalaris Therapeutics Inc
ONCYOncolytics Biotech Inc.